Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022

Upgrades

According to Jefferies, the prior rating for Target Corp TGT was changed from Hold to Buy. Target earned $0.39 in the second quarter, compared to $3.64 in the year-ago quarter. The current stock performance of Target shows a 52-week-high of $254.87 and a 52-week-low of $137.16. Moreover, at the end of the last trading period, the closing price was at $149.25.

According to Redburn Partners, the prior rating for MongoDB Inc MDB was changed from Sell to Neutral. For the second quarter, MongoDB had an EPS of $0.23, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $519.54 and a 52-week-low of $166.61. At the end of the last trading period, MongoDB closed at $182.35.

For Diamondrock Hospitality Co DRH, Evercore ISI Group upgraded the previous rating of In-Line to Outperform. In the second quarter, Diamondrock Hospitality showed an EPS of $0.36, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.14 and a 52-week-low of $7.18. Diamondrock Hospitality closed at $8.50 at the end of the last trading period.

B of A Securities upgraded the previous rating for Owens-Corning Inc OC from Underperform to Buy. Owens-Corning earned $3.83 in the second quarter, compared to $2.60 in the year-ago quarter. The stock has a 52-week-high of $101.12 and a 52-week-low of $72.97. At the end of the last trading period, Owens-Corning closed at $82.43.

For Juniper Networks Inc JNPR, Piper Sandler upgraded the previous rating of Underweight to Neutral. In the second quarter, Juniper Networks showed an EPS of $0.42, compared to $0.43 from the year-ago quarter. The current stock performance of Juniper Networks shows a 52-week-high of $38.14 and a 52-week-low of $25.18. Moreover, at the end of the last trading period, the closing price was at $26.61.

Raymond James upgraded the previous rating for Enviva Inc EVA from Outperform to Strong Buy. In the second quarter, Enviva showed an EPS of $0.26, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $91.06 and a 52-week-low of $45.88. Enviva closed at $52.31 at the end of the last trading period.

According to Goldman Sachs, the prior rating for EOG Resources Inc EOG was changed from Neutral to Buy. For the second quarter, EOG Resources had an EPS of $2.74, compared to year-ago quarter EPS of $1.73. The stock has a 52-week-high of $147.99 and a 52-week-low of $88.29. At the end of the last trading period, EOG Resources closed at $120.90.

Cowen & Co. upgraded the previous rating for Xylem Inc XYL from Market Perform to Outperform. In the second quarter, Xylem showed an EPS of $0.66, compared to $0.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $121.05 and a 52-week-low of $72.08. Xylem closed at $90.55 at the end of the last trading period.

According to Barclays, the prior rating for Jamf Holding Corp JAMF was changed from Equal-Weight to Overweight. For the second quarter, Jamf Holding had an EPS of $0.03, compared to year-ago quarter EPS of $0.05. The current stock performance of Jamf Holding shows a 52-week-high of $39.62 and a 52-week-low of $19.20. Moreover, at the end of the last trading period, the closing price was at $21.34.

RBC Capital upgraded the previous rating for PotlatchDeltic Corp PCH from Sector Perform to Outperform. For the second quarter, PotlatchDeltic had an EPS of $1.61, compared to year-ago quarter EPS of $2.77. The current stock performance of PotlatchDeltic shows a 52-week-high of $60.70 and a 52-week-low of $39.10. Moreover, at the end of the last trading period, the closing price was at $42.63.

See all analyst ratings upgrades.

Downgrades

According to Roth Capital, the prior rating for Acushnet Holdings Corp GOLF was changed from Buy to Neutral. Acushnet Hldgs earned $0.91 in the second quarter, compared to $1.08 in the year-ago quarter. The current stock performance of Acushnet Hldgs shows a 52-week-high of $53.94 and a 52-week-low of $37.46. Moreover, at the end of the last trading period, the closing price was at $45.76.

William Blair downgraded the previous rating for Green Dot Corp GDOT from Outperform to Market Perform. Green Dot earned $0.74 in the second quarter, compared to $0.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $38.14 and a 52-week-low of $17.50. Green Dot closed at $19.29 at the end of the last trading period.

Barclays downgraded the previous rating for The Descartes Systems Group Inc DSGX from Equal-Weight to Underweight. In the second quarter, Descartes Systems Gr showed an EPS of $0.27, compared to $0.27 from the year-ago quarter. The current stock performance of Descartes Systems Gr shows a 52-week-high of $82.86 and a 52-week-low of $56.19. Moreover, at the end of the last trading period, the closing price was at $68.36.

Deutsche Bank downgraded the previous rating for Packaging Corp of America PKG from Hold to Sell. For the second quarter, Packaging Corp of America had an EPS of $3.23, compared to year-ago quarter EPS of $2.17. At the moment, the stock has a 52-week-high of $168.50 and a 52-week-low of $110.56. Packaging Corp of America closed at $115.94 at the end of the last trading period.

According to Deutsche Bank, the prior rating for International Paper Co IP was changed from Hold to Sell. International Paper earned $1.24 in the second quarter, compared to $1.06 in the year-ago quarter. The current stock performance of International Paper shows a 52-week-high of $50.23 and a 52-week-low of $30.69. Moreover, at the end of the last trading period, the closing price was at $33.23.

For Masco Corp MAS, B of A Securities downgraded the previous rating of Neutral to Underperform. Masco earned $1.14 in the second quarter, compared to $1.14 in the year-ago quarter. The current stock performance of Masco shows a 52-week-high of $71.06 and a 52-week-low of $45.27. Moreover, at the end of the last trading period, the closing price was at $47.81.

For Hayward Holdings Inc HAYW, B of A Securities downgraded the previous rating of Neutral to Underperform. Hayward Holdings earned $0.29 in the second quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $26.38 and a 52-week-low of $8.30. Hayward Holdings closed at $9.01 at the end of the last trading period.

According to Wedbush, the prior rating for Carvana Co CVNA was changed from Outperform to Neutral. For the second quarter, Carvana had an EPS of $2.35, compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $240.58 and a 52-week-low of $17.05. At the end of the last trading period, Carvana closed at $18.22.

B of A Securities downgraded the previous rating for Mohawk Industries Inc MHK from Neutral to Underperform. In the second quarter, Mohawk Industries showed an EPS of $4.41, compared to $4.45 from the year-ago quarter. The stock has a 52-week-high of $192.00 and a 52-week-low of $88.84. At the end of the last trading period, Mohawk Industries closed at $96.51.

According to JMP Securities, the prior rating for Palomar Holdings Inc PLMR was changed from Market Outperform to Market Perform. In the second quarter, Palomar Hldgs showed an EPS of $0.73, compared to $0.51 from the year-ago quarter. The current stock performance of Palomar Hldgs shows a 52-week-high of $95.20 and a 52-week-low of $44.01. Moreover, at the end of the last trading period, the closing price was at $89.16.

Goldman Sachs downgraded the previous rating for PDC Energy Inc PDCE from Buy to Neutral. In the second quarter, PDC Energy showed an EPS of $5.11, compared to $1.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $89.22 and a 52-week-low of $48.52. PDC Energy closed at $67.21 at the end of the last trading period.

For WalkMe Ltd WKME, Barclays downgraded the previous rating of Overweight to Equal-Weight. For the second quarter, WalkMe had an EPS of $0.19, compared to year-ago quarter EPS of $0.16. The current stock performance of WalkMe shows a 52-week-high of $19.98 and a 52-week-low of $7.60. Moreover, at the end of the last trading period, the closing price was at $8.05.

According to Barclays, the prior rating for Pegasystems Inc PEGA was changed from Equal-Weight to Underweight. For the second quarter, Pegasystems had an EPS of $0.38, compared to year-ago quarter EPS of $0.23. The current stock performance of Pegasystems shows a 52-week-high of $111.73 and a 52-week-low of $29.05. Moreover, at the end of the last trading period, the closing price was at $32.34.

Cowen & Co. downgraded the previous rating for ForgeRock Inc FORG from Outperform to Market Perform. In the second quarter, ForgeRock showed an EPS of $0.17, compared to $0.40 from the year-ago quarter. The current stock performance of ForgeRock shows a 52-week-high of $27.61 and a 52-week-low of $11.94. Moreover, at the end of the last trading period, the closing price was at $22.54.

Barclays downgraded the previous rating for UiPath Inc PATH from Overweight to Equal-Weight. UiPath earned $0.02 in the second quarter, compared to $0.01 in the year-ago quarter. The current stock performance of UiPath shows a 52-week-high of $44.13 and a 52-week-low of $11.10. Moreover, at the end of the last trading period, the closing price was at $12.13.

Cowen & Co. downgraded the previous rating for KnowBe4 Inc KNBE from Outperform to Market Perform. KnowBe4 earned $0.07 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $26.00 and a 52-week-low of $13.78. KnowBe4 closed at $24.49 at the end of the last trading period.

RBC Capital downgraded the previous rating for NeuBase Therapeutics Inc NBSE from Outperform to Sector Perform. In the third quarter, NeuBase Therapeutics showed an EPS of $0.26, compared to $0.29 from the year-ago quarter. The current stock performance of NeuBase Therapeutics shows a 52-week-high of $3.18 and a 52-week-low of $0.27. Moreover, at the end of the last trading period, the closing price was at $0.31.

According to UBS, the prior rating for RPM International Inc RPM was changed from Buy to Neutral. In the first quarter, RPM International showed an EPS of $1.47, compared to $1.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $101.48 and a 52-week-low of $74.56. RPM International closed at $91.78 at the end of the last trading period.

According to Goldman Sachs, the prior rating for NGM Biopharmaceuticals Inc NGM was changed from Buy to Neutral. For the second quarter, NGM Biopharmaceuticals had an EPS of $0.59, compared to year-ago quarter EPS of $0.48. At the moment, the stock has a 52-week-high of $19.14 and a 52-week-low of $2.92. NGM Biopharmaceuticals closed at $3.41 at the end of the last trading period.

For ACM Research Inc ACMR, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. ACM Research earned $0.22 in the second quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $91.59 and a 52-week-low of $7.56. At the end of the last trading period, ACM Research closed at $8.13.

According to Raymond James, the prior rating for NGM Biopharmaceuticals Inc NGM was changed from Strong Buy to Outperform. For the second quarter, NGM Biopharmaceuticals had an EPS of $0.59, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $19.14 and a 52-week-low of $2.92. At the end of the last trading period, NGM Biopharmaceuticals closed at $3.41.

RBC Capital downgraded the previous rating for Resolute Forest Products Inc RFP from Outperform to Sector Perform. In the second quarter, Resolute Forest Prods showed an EPS of $2.00, compared to $3.74 from the year-ago quarter. The current stock performance of Resolute Forest Prods shows a 52-week-high of $21.07 and a 52-week-low of $11.00. Moreover, at the end of the last trading period, the closing price was at $20.86.

For Syneos Health Inc SYNH, JP Morgan downgraded the previous rating of Overweight to Neutral. For the second quarter, Syneos Health had an EPS of $1.25, compared to year-ago quarter EPS of $0.97. At the moment, the stock has a 52-week-high of $102.67 and a 52-week-low of $44.22. Syneos Health closed at $48.19 at the end of the last trading period.

According to BTIG, the prior rating for RingCentral Inc RNG was changed from Buy to Neutral. In the second quarter, RingCentral showed an EPS of $0.45, compared to $0.32 from the year-ago quarter. The current stock performance of RingCentral shows a 52-week-high of $194.40 and a 52-week-low of $31.30. Moreover, at the end of the last trading period, the closing price was at $34.29.

See all analyst ratings downgrades.

Initiations

Craig-Hallum initiated coverage on Viant Technology Inc DSP with a Buy rating. The price target for Viant Technology is set to $7.00. Viant Technology earned $0.08 in the second quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $10.23 and a 52-week-low of $3.85. At the end of the last trading period, Viant Technology closed at $4.15.

Lake Street initiated coverage on Domo Inc DOMO with a Buy rating. The price target for Domo is set to $25.00. In the second quarter, Domo showed an EPS of $0.26, compared to $0.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $57.41 and a 52-week-low of $14.00. Domo closed at $15.78 at the end of the last trading period.

DA Davidson initiated coverage on PropTech Investment Corp II PTIC with a Buy rating. The price target for PropTech Investment is set to $12.00.

With an Outperform rating, Keefe, Bruyette & Woods initiated coverage on Esquire Financial Holdings Inc ESQ. The price target seems to have been set at $53.00 for Esquire Financial Hldgs. In the second quarter, Esquire Financial Hldgs showed an EPS of $0.78, compared to $0.57 from the year-ago quarter. The current stock performance of Esquire Financial Hldgs shows a 52-week-high of $41.68 and a 52-week-low of $31.59. Moreover, at the end of the last trading period, the closing price was at $38.88.

Evercore ISI Group initiated coverage on Kimberly-Clark Corp KMB with an In-Line rating. In the second quarter, Kimberly-Clark showed an EPS of $1.34, compared to $1.47 from the year-ago quarter. The current stock performance of Kimberly-Clark shows a 52-week-high of $145.79 and a 52-week-low of $108.74. Moreover, at the end of the last trading period, the closing price was at $114.18.

Evercore ISI Group initiated coverage on Clorox Co CLX with an Underperform rating. For the fourth quarter, Clorox had an EPS of $0.93, compared to year-ago quarter EPS of $0.95. At the moment, the stock has a 52-week-high of $186.86 and a 52-week-low of $120.50. Clorox closed at $133.19 at the end of the last trading period.

With a Equal-Weight rating, Morgan Stanley initiated coverage on The Trade Desk Inc TTD. The price target seems to have been set at $60.00 for Trade Desk. For the second quarter, Trade Desk had an EPS of $0.20, compared to year-ago quarter EPS of $0.18. The stock has a 52-week-high of $93.26 and a 52-week-low of $39.00. At the end of the last trading period, Trade Desk closed at $54.61.

With a Buy rating, UBS initiated coverage on ProKidney Corp PROK. The price target seems to have been set at $18.00 for ProKidney. For the second quarter, ProKidney had an EPS of $0.12, compared to year-ago quarter EPS of $0.09. The current stock performance of ProKidney shows a 52-week-high of $11.98 and a 52-week-low of $6.19. Moreover, at the end of the last trading period, the closing price was at $9.97.

EF Hutton initiated coverage on Bone Biologics Corp BBLG with a Buy rating. The price target for Bone Biologics is set to $2.25. In the second quarter, Bone Biologics showed an EPS of $0.05, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $6.78 and a 52-week-low of $0.50. Bone Biologics closed at $0.53 at the end of the last trading period.

Truist Securities initiated coverage on Keros Therapeutics Inc KROS with a Buy rating. The price target for Keros Therapeutics is set to $100.00. In the second quarter, Keros Therapeutics showed an EPS of $1.13, compared to $0.67 from the year-ago quarter. At the moment, the stock has a 52-week-high of $68.29 and a 52-week-low of $24.38. Keros Therapeutics closed at $46.25 at the end of the last trading period.

JMP Securities initiated coverage on Benitec Biopharma Inc BNTC with a Market Outperform rating. The price target for Benitec Biopharma is set to $4.00. In the fourth quarter, Benitec Biopharma showed an EPS of $0.62, compared to $0.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.05 and a 52-week-low of $0.20. Benitec Biopharma closed at $0.24 at the end of the last trading period.

With a Market Outperform rating, JMP Securities initiated coverage on Exelixis Inc EXEL. The price target seems to have been set at $26.00 for Exelixis. In the second quarter, Exelixis showed an EPS of $0.28, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.40 and a 52-week-low of $14.87. Exelixis closed at $16.33 at the end of the last trading period.

Wolfe Research initiated coverage on Simon Property Group Inc SPG with a Peer Perform rating. Simon Property Group earned $2.91 in the second quarter, compared to $3.24 in the year-ago quarter. The current stock performance of Simon Property Group shows a 52-week-high of $165.83 and a 52-week-low of $86.02. Moreover, at the end of the last trading period, the closing price was at $99.15.

Barclays initiated coverage on Intuitive Surgical Inc ISRG with an Overweight rating. The price target for Intuitive Surgical is set to $235.00. The current stock performance of Intuitive Surgical shows a 52-week-high of $362.00 and a 52-week-low of $180.07. Moreover, at the end of the last trading period, the closing price was at $190.12.

Barclays initiated coverage on Abbott Laboratories ABT with an Overweight rating. The price target for Abbott Laboratories is set to $118.00. For the second quarter, Abbott Laboratories had an EPS of $1.43, compared to year-ago quarter EPS of $1.17. The current stock performance of Abbott Laboratories shows a 52-week-high of $139.83 and a 52-week-low of $96.67. Moreover, at the end of the last trading period, the closing price was at $103.52.

Barclays initiated coverage on Zimmer Biomet Holdings Inc ZBH with an Underweight rating. The price target for Zimmer Biomet Holdings is set to $104.00. Zimmer Biomet Holdings earned $1.82 in the second quarter, compared to $1.90 in the year-ago quarter. The stock has a 52-week-high of $135.05 and a 52-week-low of $100.39. At the end of the last trading period, Zimmer Biomet Holdings closed at $110.51.

Barclays initiated coverage on Baxter International Inc BAX with an Overweight rating. The price target for Baxter Intl is set to $64.00. In the second quarter, Baxter Intl showed an EPS of $0.87, compared to $0.80 from the year-ago quarter. The stock has a 52-week-high of $89.70 and a 52-week-low of $53.78. At the end of the last trading period, Baxter Intl closed at $55.25.

With an Overweight rating, Barclays initiated coverage on Tandem Diabetes Care Inc TNDM. The price target seems to have been set at $75.00 for Tandem Diabetes Care. In the second quarter, Tandem Diabetes Care showed an EPS of $0.24, compared to $0.06 from the year-ago quarter. The current stock performance of Tandem Diabetes Care shows a 52-week-high of $150.64 and a 52-week-low of $42.90. Moreover, at the end of the last trading period, the closing price was at $55.10.

Barclays initiated coverage on Boston Scientific Corp BSX with an Overweight rating. The price target for Boston Scientific is set to $49.00. In the second quarter, Boston Scientific showed an EPS of $0.44, compared to $0.40 from the year-ago quarter. The current stock performance of Boston Scientific shows a 52-week-high of $47.49 and a 52-week-low of $34.98. Moreover, at the end of the last trading period, the closing price was at $40.86.

Barclays initiated coverage on Stryker Corp SYK with an Overweight rating. The price target for Stryker is set to $239.00. In the second quarter, Stryker showed an EPS of $2.25, compared to $2.25 from the year-ago quarter. The stock has a 52-week-high of $280.43 and a 52-week-low of $188.84. At the end of the last trading period, Stryker closed at $215.63.

Barclays initiated coverage on NuVasive Inc NUVA with an Overweight rating. The price target for NuVasive is set to $53.00. For the second quarter, NuVasive had an EPS of $0.47, compared to year-ago quarter EPS of $0.60. The current stock performance of NuVasive shows a 52-week-high of $60.47 and a 52-week-low of $39.57. Moreover, at the end of the last trading period, the closing price was at $42.05.

With a Equal-Weight rating, Barclays initiated coverage on DexCom Inc DXCM. The price target seems to have been set at $103.00 for DexCom. In the second quarter, DexCom showed an EPS of $0.17, compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $539.06 and a 52-week-low of $67.11. DexCom closed at $99.73 at the end of the last trading period.

Barclays initiated coverage on Medtronic PLC MDT with a Equal-Weight rating. The price target for Medtronic is set to $90.00. Medtronic earned $1.13 in the first quarter, compared to $1.41 in the year-ago quarter. The current stock performance of Medtronic shows a 52-week-high of $114.31 and a 52-week-low of $79.44. Moreover, at the end of the last trading period, the closing price was at $82.76.

Barclays initiated coverage on Edwards Lifesciences Corp EW with an Overweight rating. The price target for Edwards Lifesciences is set to $96.00. For the second quarter, Edwards Lifesciences had an EPS of $0.63, compared to year-ago quarter EPS of $0.64. At the moment, the stock has a 52-week-high of $131.10 and a 52-week-low of $80.69. Edwards Lifesciences closed at $85.49 at the end of the last trading period.

With an Overweight rating, Barclays initiated coverage on Globus Medical Inc GMED. The price target seems to have been set at $69.00 for Globus Medical. For the second quarter, Globus Medical had an EPS of $0.56, compared to year-ago quarter EPS of $0.56. The stock has a 52-week-high of $81.78 and a 52-week-low of $52.60. At the end of the last trading period, Globus Medical closed at $63.95.

Barclays initiated coverage on Insulet Corp PODD with a Equal-Weight rating. The price target for Insulet is set to $238.00. For the second quarter, Insulet had an EPS of $0.06, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $283.28 and a 52-week-low of $181.00. At the end of the last trading period, Insulet closed at $224.16.

With a Buy rating, Rosenblatt initiated coverage on Bentley Systems Inc BSY. The price target seems to have been set at $37.00 for Bentley Systems. In the second quarter, Bentley Systems showed an EPS of $0.22, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $48.91 and a 52-week-low of $26.32. Bentley Systems closed at $32.51 at the end of the last trading period.

See all analyst ratings initiations.

Posted In: BZI-RatingsUpgradesDowngradesInitiationIntraday UpdateAnalyst Ratings